Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study

References

• Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38(1):18–31.
   PubMed Web of Science ®Google Scholar
• Poon LC, Wright D, Rolnik DL, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217(5):585.e1–585.e5.
   PubMed Web of Science ®Google Scholar
• Brosens I, Pijnenborg R, Vercruysse L, et al. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201.
   PubMed Web of Science ®Google Scholar
• Audibert F, Boucoiran I, An N, et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol. 2010;203(4):383.e1–383.e8.
   Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Whitten A, et al. Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa. J Perinat Med. 2013;41(5):485–504.
   PubMed Web of Science ®Google Scholar
• Madan I, Than NG, Romero R, et al. The peripheral whole-blood transcriptome of acute pyelonephritis in human pregnancya. J Perinat Med. 2014;42(1):31–53.
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Gotsch F, et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG Int J Obstet Gynaecol. 2006;113(3):118–135.
   PubMedGoogle Scholar
• Bujold E, Romero R, Kusanovic JP, et al. Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry. J Matern Fetal Neonatal Med. 2008;21(10):697–713.
   PubMed Web of Science ®Google Scholar
• Romero R, Kusanovic JP, Gotsch F, et al. Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med. 2010;23(4):261–280.
   PubMed Web of Science ®Google Scholar
• Auer J, Camoin L, Guillonneau F, et al. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics. 2010;73(5):1004–1017.
   PubMed Web of Science ®Google Scholar
• Kacerovsky M, Lenco J, Musilova I, et al. Proteomic biomarkers for spontaneous preterm birth: a systematic review of the literature. Reprod Sci. 2014;21(3):283–295.
   PubMed Web of Science ®Google Scholar
• Anand S, Bench Alvarez TM, Johnson WE, et al. Serum biomarkers predictive of pre-eclampsia. Biomarkers Med. 2015;9(6):563–575.
   PubMed Web of Science ®Google Scholar
• Kolialexi A, Mavreli D, Tounta G, et al. Urine proteomic studies in preeclampsia. Prot Clin Appl. 2015;9(5–6):501–506.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Maymon E, et al. The prediction of late-onset preeclampsia: results from a longitudinal proteomics study. PLoS One. 2017;12(7):e0181468.
   PubMed Web of Science ®Google Scholar
• Kolialexi A, Tsangaris GT, Sifakis S, et al. Plasma biomarkers for the identification of women at risk for early-onset preeclampsia. Expert Rev Proteomics. 2017;14(3):269–276.
   PubMed Web of Science ®Google Scholar
• Romero R, Mazaki-Tovi S, Vaisbuch E, et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med. 2010;23(12):1344–1359.
   PubMed Web of Science ®Google Scholar
• Bahado-Singh RO, Akolekar R, Mandal R, et al. First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013;208(1):58.e1–58.e7.
   PubMed Web of Science ®Google Scholar
• Kuc S, Koster MP, Pennings JL, et al. Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia. PLoS One. 2014;9(5):e98540.
   PubMed Web of Science ®Google Scholar
• Austdal M, Tangerås LH, Skråstad RB, et al. First trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study. IJMS. 2015;16(9):21520–21538.
   Google Scholar
• Baraldi E, Giordano G, Stocchero M, et al. Untargeted metabolomic analysis of amniotic fluid in the prediction of preterm delivery and bronchopulmonary dysplasia. PLoS One. 2016;11(10):e0164211.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Espinoza J, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008;21(5):279–287.
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Sunderland N, Thornton C, et al. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy. Am J Obstet Gynecol. 2017;216(2):170.e1–170.e8.
   Web of Science ®Google Scholar
• Than NG, Romero R, Xu Y, et al. Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia. Placenta. 2014;35(11):855–865.
   PubMed Web of Science ®Google Scholar
• Ngo TTM, Moufarrej MN, Rasmussen MH, et al. Noninvasive blood tests for fetal development predict gestational age and preterm delivery. Science. 2018;360(6393):1133–1136.
   PubMed Web of Science ®Google Scholar
• Than NG, Romero R, Tarca AL, et al. Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia. Front Immunol. 2018;9:1661.
   PubMed Web of Science ®Google Scholar
• Tsang JCH, Vong JSL, Ji L, et al. Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics. Proc Natl Acad Sci USA. 2017;114(37):E7786–E7795.
   PubMed Web of Science ®Google Scholar
• Moldenhauer JS, Stanek J, Warshak C, et al. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol. 2003;189(4):1173–1177.
   PubMed Web of Science ®Google Scholar
• Sebire NJ, Goldin RD, Regan L. Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol J Inst Obstet Gynaecol. 2005;25(2):117–118.
   Google Scholar
• van der Merwe JL, Hall DR, Wright C, et al. Are early and late preeclampsia distinct subclasses of the disease – what does the placenta reveal? Hypertens Preg. 2010;29(4):457–467.
   PubMed Web of Science ®Google Scholar
• Ogge G, Chaiworapongsa T, Romero R, et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med. 2011;39(6):641–652.
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99(1):159–167.
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Preg. 2003;22(2):143–148.
   PubMed Web of Science ®Google Scholar
• Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol. 1996;87(2):163–168.
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–264.
   PubMed Web of Science ®Google Scholar
• Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26(19):2363–2367.
   PubMed Web of Science ®Google Scholar
• Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80.
   PubMed Web of Science ®Google Scholar
• Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey VJ, Huber W, editors. Bioinformatics and computational biology solutions using R and bioconductor. New York (NY): Springer; 2012.
   Google Scholar
• Hagenauer MH, Schulmann A, Li JZ, et al. Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis. PLoS One. 2018;13(7):e0200003.
   PubMed Web of Science ®Google Scholar
• Tarca AL, Than NG, Romero R. Methodological approach from the best overall team in the sbv IMPROVER Diagnostic Signature Challenge. Syst Biomed. 2013;1(4):217–227.
   Google Scholar
• Tarca AL, Lauria M, Unger M, et al. Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge. Bioinformatics. 2013;29(22):2892–2899.
   PubMed Web of Science ®Google Scholar
• Dayarian A, Romero R, Wang Z, et al. Predicting protein phosphorylation from gene expression: top methods from the IMPROVER Species Translation Challenge. Bioinformatics. 2015;31(4):462–470.
   PubMed Web of Science ®Google Scholar
• Gardosi J, Francis A. A customized standard to assess fetal growth in a US population. Am J Obstet Gynecol. 2009;201(1):25.e1–25.e7.
   Web of Science ®Google Scholar
• Gómez O, Figueras F, Fernández S, et al. Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32(2):128–132.
   PubMed Web of Science ®Google Scholar
• Arduini D, Rizzo G. Normal values of Pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses. J Perinat Med. 1990;18(3):165–172.
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9–23.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LCY, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):492–495.
   PubMed Web of Science ®Google Scholar
• O’Gorman N, Wright D, Poon LC, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017;49(6):751–755.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Etchegaray A, Zhou Y, et al. Maternal serum activin a at 11–13 weeks of gestation in hypertensive disorders of pregnancy. Fetal Diagn Ther. 2009;25(3):320–327.
   PubMed Web of Science ®Google Scholar
• Matrisian LM, Wright J, Newell K, et al. Matrix-degrading metalloproteinases in tumor progression. Int Symp Princess Takamatsu Cancer Res Fund. 1994;24:152–161.
   PubMedGoogle Scholar
• Cohen T, Gitay-Goren H, Sharon R, et al. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem. 1995;270(19):11322–11326.
   PubMed Web of Science ®Google Scholar
• Chung JY, Song Y, Wang Y, et al. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies. J Clin Endocrinol Metab. 2004;89(5):2484–2490.
   PubMed Web of Science ®Google Scholar
• Lian IA, Toft JH, Olsen GD, et al. Matrix metalloproteinase 1 in pre-eclampsia and fetal growth restriction: reduced gene expression in decidual tissue and protein expression in extravillous trophoblasts. Placenta. 2010;31(7):615–620.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Rabaglino MB, Post Uiterweer ED. Emerging role for dysregulated decidualization in the genesis of preeclampsia. Placenta. 2017;60:119–129.
   PubMed Web of Science ®Google Scholar
• Rabaglino MB, Post Uiterweer ED, Jeyabalan A, et al. Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia. Hypertension. 2015;65(2):421–429.
   PubMed Web of Science ®Google Scholar
• Luo S, Cao N, Tang Y, et al. Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis. PLoS One. 2017;12(6):e0178549.
   PubMed Web of Science ®Google Scholar
• Vaiman D, Miralles F. An integrative analysis of preeclampsia based on the construction of an extended composite network featuring protein–protein physical interactions and transcriptional relationships. PLoS One. 2016;11(11):e0165849.
   PubMed Web of Science ®Google Scholar
• Kim MS, Yu JH, Lee MY, et al. Differential expression of extracellular matrix and adhesion molecules in fetal-origin amniotic epithelial cells of preeclamptic pregnancy. PLoS One. 2016;11(5):e0156038.
   PubMed Web of Science ®Google Scholar
• van Uitert M, Moerland PD, Enquobahrie DA, et al. Meta-analysis of placental transcriptome data identifies a novel molecular pathway related to preeclampsia. PLoS One. 2015;10(7):e0132468.
   PubMed Web of Science ®Google Scholar
• Textoris J, Ivorra D, Ben Amara A, et al. Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker. PLoS One. 2013;8(12):e82638.
   PubMed Web of Science ®Google Scholar
• Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol. 1991;18(4):661–682.
   PubMed Web of Science ®Google Scholar
• Várkonyi T, Nagy B, Füle T, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta. 2011;32:S21–S29.
   PubMed Web of Science ®Google Scholar
• Zwemer LM, Nolin SL, Okamoto PM, et al. Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions. Prenat Diagn. 2017;37(1):43–52.
   PubMed Web of Science ®Google Scholar
• Tarca AL, Romero R, Xu Z, et al. Targeted expression profiling by RNA-Seq improves detection of cellular dynamics during pregnancy and identifies a role for T cells in term parturition. Sci Rep. 2019;9(1):848.
   PubMedGoogle Scholar
• Kleinrouweler CE, van Uitert M, Moerland PD, et al. Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis. PLoS One. 2013;8(7):e68991.
   PubMed Web of Science ®Google Scholar
• Buckberry S, Bianco-Miotto T, Bent SJ, et al. Placental transcriptome co-expression analysis reveals conserved regulatory programs across gestation. BMC Genom. 2017;18(1):10.
   PubMedGoogle Scholar
• Brew O, Sullivan MH, Woodman A. Comparison of normal and pre-eclamptic placental gene expression: a systematic review with meta-analysis. PLoS One. 2016;11(8):e0161504.
   PubMed Web of Science ®Google Scholar
• Yong HE, Melton PE, Johnson MP, et al. Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes. PLoS One. 2015;10(5):e0128230.
   PubMed Web of Science ®Google Scholar
• Kaartokallio T, Cervera A, Kyllönen A, et al. Gene expression profiling of pre-eclamptic placentae by RNA sequencing. Sci Rep. 2015;5(1):14107.
   PubMedGoogle Scholar
• Zhao M, Li L, Yang X, et al. FN1, FOS, and ITGA5 induce preeclampsia: abnormal expression and methylation. Hypertens Preg. 2017;36(4):302–309.
   PubMed Web of Science ®Google Scholar
• Xu J, Xia Y, Zhang H, et al. Overexpression of long non-coding RNA H19 promotes invasion and autophagy via the PI3K/AKT/mTOR pathways in trophoblast cells. Biomed Pharmacother. 2018;101:691–697.
   PubMed Web of Science ®Google Scholar
• Tarca AL, Romero R, Benshalom-Tirosh N, et al. The prediction of early preeclampsia: results from a longitudinal proteomics study. PLoS One. 2019;14(6):e0217273.
   PubMed Web of Science ®Google Scholar